Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medikan International is a private healthcare company focused on medical and surgical equipment, particularly devices used in plastic surgery, fat grafting, stromal vascular fraction isolation, and related regenerative medicine workflows. Available evidence indicates that it operates as the U.S. corporate entity for Medikan-branded products and is engaged in medical equipment wholesale and commercialization rather than therapeutic drug development. The broader Medikan product portfolio includes fat grafting systems, stem cell or SVF isolation devices, cell culture equipment, exosome-processing workflow equipment, and sample storage systems. For biotech analysts, this appears to be a commercially active medical device business in the aesthetics and regenerative procedure ecosystem, not a classic biotech or pharma company with a disclosed drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medikan International.